Alemtuzumab As First‐ and Second‐line Treatment in Patients with Sézary Syndrome—the Experience of a Tertiary Centre
Journal of the European Academy of Dermatology and Venereology（2023）
Key words
Clinical End Points
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined